Antiphospholipid syndrome historical perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
In the early 1980s, the term antiphospholipid syndrome was coined to describe a unique form of autoantibody-induced thrombophilia. In 1999, Sapporo classification criteria for APS was published. In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti-β2 glycoprotein I (GPI) antibodies in the diagnostic criteria.
Historical Perspective
The historical perspective of antiphospholipid syndrome (APS) is as follows:[1][2][3]
- In the early 1980s, the term antiphospholipid syndrome was coined to describe a unique form of autoantibody-induced thrombophilia, whose hallmarks are complications in pregnancy complications and recurrent thrombosis.
- In 1999, Sapporo classification criteria for APS were published in an international consensus statement in Sydney, Australia.
- In 2006, the preliminary Sapporo criteria was revised with the inclusion of anti-β2 glycoprotein I antibodies in the diagnostic criteria.
References
- ↑ Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R; et al. (2006). “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)”. J Thromb Haemost. 4 (2): 295–306. doi:10.1111/j.1538-7836.2006.01753.x. PMID 16420554.
- ↑ Solano C, Lamuño M, Vargas A, Amezcua-Guerra LM (2009). “Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome”. Clin Exp Rheumatol. 27 (6): 914–9. PMID 20149305.
- ↑ Kaul M, Erkan D, Sammaritano L, Lockshin MD (2007). “Assessment of the 2006 revised antiphospholipid syndrome classification criteria”. Ann Rheum Dis. 66 (7): 927–30. doi:10.1136/ard.2006.067314. PMC 2497429. PMID 17337473.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH